Results 251 to 260 of about 303,943 (292)

Hemocompatibility and Long‐Term Outcomes in HeartWare Versus HeartMate II Versus HeartMate 3: Multicenter Real‐World Cohort

open access: yesArtificial Organs, EarlyView.
Multicenter real‐world cohort (n = 327) comparing LVADs: HeartMate 3 (HM3), HeartMate II (HMII), and HeartWare (HVAD). HM3 showed superior long‐term survival versus legacy devices, driven by fewer hemocompatibility‐related adverse events, especially pump thrombosis and ischemic stroke, while major bleeding was similar across devices.
Hamza H. H. Ben Nasir   +9 more
wiley   +1 more source

Health-related quality of life in chronic kidney disease patients in low- and lower-middle income countries: a systematic review and meta-analysis. [PDF]

open access: yesQual Life Res
Muxunov A   +9 more
europepmc   +1 more source

Determinants of Intradialytic Phosphate Removal in Hemodiafiltration From Real‐World Clinical Practice

open access: yesArtificial Organs, EarlyView.
We show that convective therapy in the form of hemodiafiltration does not demonstrate a measurable effect on phosphate removal in a real‐world setting. On the other hand, session duration is the most important factor in determining phosphate removal in hemodialysis patients.
David A. Jaques   +4 more
wiley   +1 more source

Evaluation of urine glutathione peroxidase 4 in cats with chronic kidney disease. [PDF]

open access: yesFront Vet Sci
Hsu WL   +5 more
europepmc   +1 more source

Tubulointerstitial nephritis and uveitis syndrome in children: What to keep an eye on

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose The purpose of this study was to determine the disease course in patients with tubulointerstitial nephritis and uveitis (TINU) syndrome, focusing on long‐term outcome and the incidence of complications such as chronic kidney disease (CKD).
Jytte Hendrikse   +4 more
wiley   +1 more source

Review Article: Renal Safety Profiles of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Entecavir for the Treatment of Chronic Hepatitis B Infection—General and Special Populations

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Current first‐line NUCs show comparable renal safety profiles in CHB patients with no or mild kidney dysfunction, with growing evidence that favours TAF. Future prospective studies are needed to validate these findings, and more research should focus on CHB patients with diabetes mellitus who are at risk of CKD.
Lung‐Yi Mak   +2 more
wiley   +1 more source

Stroke burden and functional impacts in adults with sickle cell disease

open access: yesBritish Journal of Haematology, EarlyView.
Stroke was identified in 4.6% of 454 adults with sickle cell disease. Stroke occurred not only across HbSS/Sβ0 phenotypes but also HbSC/Sβ+ as well, challenging traditional assumptions. Stroke was associated with long‐term functional impairment, including cognitive deficits and higher disability scores.
Jonathan St‐Onge   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy